DXCM Financial Facts
Product cost of sales: 47.5MTotal operating expenses: 119.6M
See Full Income Statement
Other assets: 1.5M
Accounts payable and accrued liabilities: 58.6M
See Full Balance Sheet
DexCom, Inc. (DXCM) Earnings
|
Expand Research on DXCM
| Next EPS Date | 4/25/24 | EPS Growth Rate | +58.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +31.1% | Revenue Growth Rate | +22.7% |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/17  |
 |
Q117 | -$0.49 | -$0.50 | +$0.01 | $142.3M | $144.47M | N/A |  | | Details |
| 5/2/18 | |
Q118 | -$0.32 | -$0.33 | +$0.01 | $184.4M | $172.08M | = | | | Details |
| 11/1/12 |
|
Q312 | -$0.25 | -$0.22 | -$0.03 | $23.1M | $23.14M | N/A | | | Details |
| 8/2/16 |
|
Q216 | -$0.24 | -$0.12 | -$0.12 | $137.3M | $132.59M | N/A | | | Details |
| 11/4/10 |
|
Q310 | -$0.23 | -$0.18 | -$0.05 | N/A | N/A | N/A | | | Details |
| 4/27/16 |
|
Q116 | -$0.23 | -$0.20 | -$0.03 | $116.2M | $110.38M | N/A | | | Details |
| 11/1/16 |
|
Q316 | -$0.22 | -$0.13 | -$0.09 | $148.6M | $146.26M | N/A | | | Details |
| 5/2/12 |
Q112 | -$0.21 | -$0.19 | -$0.02 | $20.1M | $19.88M | N/A | | | Details |
